An analysis of several hundred DIPG and related tumors, including Chad Carr’s, finds an overlooked key factor in determining prognosis for the aggressive childhood brain cancer.

Donated tumor tissue from a 5-year-old brain cancer patient uncovers the key and early role of a less-understood genetic mutation in the cancer’s fatal course.

How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.

In a new study, gene therapy deployed with immune checkpoint inhibitors demonstrates potential benefit for devastating brain cancer.